Survodutide research compound — long-acting GLP-1/glucagon dual receptor agonist for hepatic and metabolic studies.

Survodutide (BI 456906) is a once-weekly GLP-1/glucagon dual receptor agonist research compound. Its balanced dual-receptor activity makes it of particular research interest in hepatic and metabolic studies.
Survodutide engages GLP-1 and glucagon receptors with carefully balanced potency designed to capture metabolic benefits of both pathways while managing the typical hyperglycemic concerns of glucagon agonism.
Used in research investigating: hepatic lipid pathways, NASH research models, dual receptor balance optimization, comparative metabolic peptide studies.
| Compound | Survodutide |
| Available Strengths | 10mg |
| Purity | ≥99% (verified by HPLC) |
| Form | Lyophilized powder |
| Storage | -20°C, protected from light |
| Reconstitution | Bacteriostatic water (sold separately) |
| Shelf Life | 36 months (lyophilized, properly stored) |
| Certificate of Analysis | Available upon request — contact us |
Add bacteriostatic water slowly. Use within 28 days.
Lyophilized: -20°C. Reconstituted: 2-8°C.
For research use only. Not for human consumption.